Literature DB >> 35945296

SOX2 expression in the pathogenesis of premalignant lesions of the uterine cervix: its histo-topographical distribution distinguishes between low- and high-grade CIN.

Jobran M Moshi1,2, Monique Ummelen1, Jos L V Broers1, Frank Smedts3, Koen K Van de Vijver4,5, Jack P M Cleutjens4, Rogier J N T M Litjens6, Frans C S Ramaekers1, Anton H N Hopman7.   

Abstract

SOX2 expression in high-grade cervical intraepithelial neoplasia (CIN3) and cervical squamous cell carcinoma is increased compared to that in the normal cervical epithelium. However, data on the expression and histological distribution of SOX2 in squamous epithelium during progression of CIN are largely lacking. We studied SOX2 expression throughout the epithelium in 53 cases of CIN1, 2, and 3. In general, SOX2 expression increased and expanded from basal/parabasal to the intermediate/superficial compartment during early stages of progression of CIN. An unexpected, specific expression pattern was found in areas classified as CIN2 and CIN3. This pattern was characterized by the absence or low expression of SOX2 in the basal/parabasal compartment and variable levels in the intermediate and superficial compartments. It was significantly associated with CIN3 (p = 0.009), not found in CIN1 and only seen in part of the CIN2 lesions. When the different patterns were correlated with the genetic make-up and presence of HPV, the CIN3-related pattern contained HPV-positive cells in the basal/parabasal cell compartment that were disomic. This is in contrast to the areas exhibiting the CIN1 and CIN2 related patterns, which frequently exhibited aneusomic cells. Based on their SOX2 localisation pattern, CIN1 and CIN2 could be delineated from CIN3. These data shed new light on the pathogenesis and dynamics of progression in premalignant cervical lesions, as well as on the target cells in the epithelium for HPV infection.
© 2022. The Author(s).

Entities:  

Keywords:  CIN; Cervical preneoplasia; Genetic aberrations; HPV infection; SOX2 distribution; Squamous intraepithelial lesions

Year:  2022        PMID: 35945296     DOI: 10.1007/s00418-022-02145-6

Source DB:  PubMed          Journal:  Histochem Cell Biol        ISSN: 0948-6143            Impact factor:   2.531


  19 in total

1.  Sex-determining region Y-related high mobility group box (SOX)-2 is overexpressed in cervical squamous cell carcinoma and contributes cervical cancer cell migration and invasion in vitro.

Authors:  Xiaohan Chang; Jing Zhang; Chenglin Huang; Xiaoao Pang; Qingshuang Luo; Huijie Zhang; Shulan Zhang
Journal:  Tumour Biol       Date:  2015-05-03

Review 2.  SOX2 in development and cancer biology.

Authors:  Daniel Novak; Laura Hüser; Jonathan J Elton; Viktor Umansky; Peter Altevogt; Jochen Utikal
Journal:  Semin Cancer Biol       Date:  2019-08-11       Impact factor: 15.707

3.  Carcinogenic HPV infection in the cervical squamo-columnar junction.

Authors:  Jelena Mirkovic; Brooke E Howitt; Patrick Roncarati; Stephanie Demoulin; Meggy Suarez-Carmona; Pascale Hubert; Frank D McKeon; Wa Xian; Anita Li; Philippe Delvenne; Christopher P Crum; Michael Herfs
Journal:  J Pathol       Date:  2015-04-27       Impact factor: 7.996

Review 4.  The multiple roles for Sox2 in stem cell maintenance and tumorigenesis.

Authors:  Kuancan Liu; Baoshun Lin; Meng Zhao; Xiangyue Yang; Min Chen; Anding Gao; Fei Liu; Jianwen Que; Xiaopeng Lan
Journal:  Cell Signal       Date:  2013-02-15       Impact factor: 4.315

Review 5.  Sox2: A Regulatory Factor in Tumorigenesis and Metastasis.

Authors:  Sameer Chaudhary; Zeyaul Islam; Vijaya Mishra; Sakshi Rawat; Ghulam Md Ashraf; Prasanna R Kolatkar
Journal:  Curr Protein Pept Sci       Date:  2019       Impact factor: 3.272

6.  The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3.

Authors:  Rogier J N T M Litjens; Koen K Van de Vijver; Anton H N Hopman; Monique I Ummelen; Ernst-Jan M Speel; Suprapto H Sastrowijoto; Toon Van Gorp; Brigitte F M Slangen; Roy F P M Kruitwagen; Arnold-Jan Krüse
Journal:  Hum Pathol       Date:  2013-10-30       Impact factor: 3.466

7.  CK7 Immunohistochemistry as a Predictor of CIN1 Progression: A Retrospective Study of Patients From the Quadrivalent HPV Vaccine Trials.

Authors:  Anne M Mills; Cherie Paquette; Tatjana Terzic; Philip E Castle; Mark H Stoler
Journal:  Am J Surg Pathol       Date:  2017-02       Impact factor: 6.394

8.  Comprehensive control of human papillomavirus infections and related diseases.

Authors:  F Xavier Bosch; Thomas R Broker; David Forman; Anna-Barbara Moscicki; Maura L Gillison; John Doorbar; Peter L Stern; Margaret Stanley; Marc Arbyn; Mario Poljak; Jack Cuzick; Philip E Castle; John T Schiller; Lauri E Markowitz; William A Fisher; Karen Canfell; Lynette A Denny; Eduardo L Franco; Marc Steben; Mark A Kane; Mark Schiffman; Chris J L M Meijer; Rengaswamy Sankaranarayanan; Xavier Castellsagué; Jane J Kim; Maria Brotons; Laia Alemany; Ginesa Albero; Mireia Diaz; Silvia de Sanjosé
Journal:  Vaccine       Date:  2013-12-31       Impact factor: 3.641

9.  Cervical cancer cells with positive Sox2 expression exhibit the properties of cancer stem cells.

Authors:  Xiao-Fang Liu; Wen-Ting Yang; Rui Xu; Jun-Tian Liu; Peng-Sheng Zheng
Journal:  PLoS One       Date:  2014-01-28       Impact factor: 3.240

10.  SOX2 in cancer stemness: tumor malignancy and therapeutic potentials.

Authors:  Mahfuz Al Mamun; Kaiissar Mannoor; Jun Cao; Firdausi Qadri; Xiaoyuan Song
Journal:  J Mol Cell Biol       Date:  2020-02-20       Impact factor: 6.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.